GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (FRA:7JK) » Definitions » Cyclically Adjusted FCF per Share

EQL Pharma AB (FRA:7JK) Cyclically Adjusted FCF per Share : €0.00 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is EQL Pharma AB Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

EQL Pharma AB's adjusted free cash flow per share for the three months ended in Mar. 2024 was €0.159. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.00 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-06-23), EQL Pharma AB's current stock price is €4.19. EQL Pharma AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €0.00. EQL Pharma AB's Cyclically Adjusted Price-to-FCF of today is .

During the past 12 years, the highest Cyclically Adjusted Price-to-FCF of EQL Pharma AB was 2806.05. The lowest was 2105.00. And the median was 2220.00.


EQL Pharma AB Cyclically Adjusted FCF per Share Historical Data

The historical data trend for EQL Pharma AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EQL Pharma AB Cyclically Adjusted FCF per Share Chart

EQL Pharma AB Annual Data
Trend Dec14 Dec15 Dec16 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

EQL Pharma AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -0.02 -

Competitive Comparison of EQL Pharma AB's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, EQL Pharma AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EQL Pharma AB's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EQL Pharma AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where EQL Pharma AB's Cyclically Adjusted Price-to-FCF falls into.



EQL Pharma AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, EQL Pharma AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.159/132.2054*132.2054
=0.159

Current CPI (Mar. 2024) = 132.2054.

EQL Pharma AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -0.019 99.788 -0.025
201406 -0.015 100.432 -0.020
201409 -0.016 100.161 -0.021
201412 -0.023 100.225 -0.030
201503 -0.008 99.950 -0.011
201506 0.011 99.995 0.015
201509 -0.022 100.228 -0.029
201512 0.013 100.276 0.017
201603 0.006 100.751 0.008
201606 0.024 101.019 0.031
201609 0.001 101.138 0.001
201612 -0.025 102.022 -0.032
201703 0.007 102.022 0.009
201706 -0.016 102.752 -0.021
201709 -0.013 103.279 -0.017
201803 0.000 103.962 0.000
201806 -0.017 104.875 -0.021
201809 0.000 105.679 0.000
201812 0.035 105.912 0.044
201903 -0.001 105.886 -0.001
201906 -0.008 106.742 -0.010
201909 0.021 107.214 0.026
201912 -0.002 107.766 -0.002
202003 0.012 106.563 0.015
202006 0.180 107.498 0.221
202009 -0.148 107.635 -0.182
202012 -0.018 108.296 -0.022
202103 0.001 108.360 0.001
202106 -0.053 108.928 -0.064
202109 -0.011 110.338 -0.013
202112 0.041 112.486 0.048
202203 0.081 114.825 0.093
202206 0.018 118.384 0.020
202209 -0.034 122.296 -0.037
202212 -0.007 126.365 -0.007
202303 0.056 127.042 0.058
202306 -0.057 129.407 -0.058
202309 -0.011 130.224 -0.011
202312 -0.128 131.912 -0.128
202403 0.159 132.205 0.159

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


EQL Pharma AB  (FRA:7JK) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 12 years, the highest Cyclically Adjusted Price-to-FCF of EQL Pharma AB was 2806.05. The lowest was 2105.00. And the median was 2220.00.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


EQL Pharma AB Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


EQL Pharma AB (FRA:7JK) Business Description

Industry
Traded in Other Exchanges
Address
Stortorget 1, 3rd Floor, Lund, SWE, 222 23
EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB (FRA:7JK) Headlines

No Headlines